XGN

Exagen (XGN)

Exagen Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:XGN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	09:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
2024/05/15	05:25	AllPennyStocks.com	Healthcare Shares Soar Following Major Price Target Increase	NASDAQ:XGN	Exagen Inc
2024/05/13	22:30	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:XGN	Exagen Inc
2024/05/13	22:27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XGN	Exagen Inc
2024/05/13	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XGN	Exagen Inc
2024/05/13	21:00	GlobeNewswire Inc.	Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year	NASDAQ:XGN	Exagen Inc
2024/05/07	05:05	GlobeNewswire Inc.	Exagen Announces Campaign for Lupus Awareness Month	NASDAQ:XGN	Exagen Inc
2024/05/01	05:05	GlobeNewswire Inc.	Exagen to Announce First Quarter 2024 Results on May 13, 2024	NASDAQ:XGN	Exagen Inc
2024/04/26	21:30	GlobeNewswire Inc.	Exagen Inc. Announces Changes to the Board of Directors	NASDAQ:XGN	Exagen Inc
2024/03/18	21:00	GlobeNewswire Inc.	Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results	NASDAQ:XGN	Exagen Inc
2024/03/18	20:12	IH Market News	Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks	NASDAQ:XGN	Exagen Inc
2024/03/08	23:00	GlobeNewswire Inc.	Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum	NASDAQ:XGN	Exagen Inc
2024/03/08	06:05	GlobeNewswire Inc.	Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024	NASDAQ:XGN	Exagen Inc
2024/03/07	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
2024/03/05	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
2024/02/23	06:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
2024/02/23	06:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
2024/02/14	21:12	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:XGN	Exagen Inc
2024/02/14	06:35	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:XGN	Exagen Inc
2024/02/09	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XGN	Exagen Inc
2024/02/03	05:16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:XGN	Exagen Inc
2024/01/31	06:05	GlobeNewswire Inc.	Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference	NASDAQ:XGN	Exagen Inc
2024/01/23	06:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:XGN	Exagen Inc
2024/01/08	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XGN	Exagen Inc
2024/01/08	02:00	GlobeNewswire Inc.	Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance	NASDAQ:XGN	Exagen Inc
2023/12/12	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XGN	Exagen Inc
2023/11/30	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:XGN	Exagen Inc
2023/11/30	07:11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:XGN	Exagen Inc
2023/11/28	06:05	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:XGN	Exagen Inc
2023/11/20	22:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:XGN	Exagen Inc